Clinical Trial: Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma

U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT07548177) titled 'Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma' on April 17.

Brief Summary: This is a Phase II, single-arm, multicenter clinical study aimed at demonstrating the effectiveness of benmelstobart injection combined with anlotinib hydrochloride capsules in patients aged 14 years or older with advanced or unresectable alveolar soft part sarcoma by evaluating the objective response rate (IRC).

Study Start Date: April 02

Study Type: INTERVENTIONAL

Condition: Alveolar Soft Part Sarcoma

Intervention: DRUG: Benmelstobart i...